Figure 1. Treatment of 3T3/TrkA cells with NGF stimulates phosphorylation of TrkA at Tyr490, detected by PathScan® Phospho-TrkA (Tyr490) Sandwich ELISA Kit #7210, but does not affect the level of total TrkA detected by PathScan® Total TrkA Sandwich ELISA Kit #7208. OD 450 readings are shown in the top figure, while the corresponding western blot using Phospho-TrkA (Tyr490) Antibody #9141 (right panel) or TrkA Rabbit mAb #2505 (left panel), is shown in the bottom figure. The human TrkA is expressed in 3T3/TrkA cells.Learn more about how we get our images
Figure 2. The relationship between protein concentration of lysates from untreated and NGF-treated 3T3/TrkA cells and kit assay optical density readings is shown. After starvation, 3T3/TrkA cells (85% confluence) were treated with NGF (100 ng/ml) for 2 min at 37°C, and then lysed.Learn more about how we get our images
|Product Includes||Volume||Solution Color|
|TrkA Mouse mAb Coated Microwells||96 tests|
|Phospho-TrkA (Tyr490)/TrkB (Tyr516) Rabbit Detection mAb||1 ea||Green (Lyophilized)|
|Anti-rabbit IgG, HRP-linked Antibody (ELISA Formulated)||1 ea||Red (Lyophilized)|
|Detection Antibody Diluent||11 ml||Green|
|HRP Diluent||11 ml||Red|
|TMB Substrate 7004||11 ml||Colorless|
|STOP Solution 7002||11 ml||Colorless|
|ELISA Wash Buffer (20X)||25 ml||Colorless|
|ELISA Sample Diluent||25 ml||Blue|
|Sealing Tape||2 ea|
|Cell Lysis Buffer (10X) 9803||15 ml|
NOTE: Prepare solutions with purified water.
*NOTE: Some PathScan® ELISA Kits may include HRP-Linked Streptavidin in place of HRP-Linked Antibody.
NOTE: Initial color of positive reaction is blue, which changes to yellow upon addition of STOP Solution.
posted November 2013
PathScan® Phospho-TrkA (Tyr490) Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects phospho-TrkA (Tyr490) protein. A TrkA Mouse mAb has been coated onto the microwells. After incubation with cell lysates, both phospho- and nonphospho-TrkA proteins are captured by the coated antibody. Following extensive washing, Phospho-TrkA (Tyr490) Antibody is added to detect phospho-TrkA protein. Anti-rabbit IgG, HRP-linked Antibody is then used to recognize the bound detection antibody. HRP substrate, TMB, is added to develop color. The magnitude of optical density for this developed color is proportional to the quantity of Phospho-TrkA (Tyr490) protein.
Antibodies in kit are custom formulations specific to kit.
PathScan® Phospho-TrkA (Tyr490) Sandwich ELISA Kit #7210 detects phospho-TrkA (Tyr490) Protein. As shown in Figure 1, using this ELISA Kit #7210, a significant induction of Phospho-TrkA (Tyr490) is detected in 3T3/TrkA cells treated with NGF. However, levels of total TrkA (phospho and nonphospho) detected by PathScan® Total TrkA Sandwich ELISA Kit #7208, remain unchanged (Figure 1). This kit detects proteins from the indicated species, as determined through in-house testing, but may also detect homologous proteins from other species.
The family of Trk receptor tyrosine kinases consists of TrkA, TrkB, and TrkC. While the sequence of these family members is highly conserved, they are activated by different neurotrophins: TrkA by NGF, TrkB by BDNF or NT4, and TrkC by NT3 (1). Neurotrophin signaling through these receptors regulates a number of physiological processes, such as cell survival, proliferation, neural development, and axon and dendrite growth and patterning (1). In the adult nervous system, the Trk receptors regulate synaptic strength and plasticity. TrkA regulates proliferation and is important for development and maturation of the nervous system (2). Phosphorylation at Tyr490 is required for Shc association and activation of the Ras-MAP kinase cascade (3,4). Residues Tyr674/675 lie within the catalytic domain, and phosphorylation at these sites reflects TrkA kinase activity (3-6). Point mutations, deletions, and chromosomal rearrangements (chimeras) cause ligand-independent receptor dimerization and activation of TrkA (7-10). TrkA is activated in many malignancies including breast, ovarian, prostate, and thyroid carcinomas (8-13). Research studies suggest that expression of TrkA in neuroblastomas may be a good prognostic marker as TrkA signals growth arrest and differentiation of cells originating from the neural crest (10).
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc. PathScan is a trademark of Cell Signaling Technology, Inc. U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.
Explore pathways related to this product.
|7210C||1 Kit (96 assays)||$ 489.0|